Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
4
|
| pubmed:dateCreated |
1998-9-1
|
| pubmed:abstractText |
French and American consensus conferences on hepatitis C confirmed the burden of that disease, especially in high risk populations. In France, the seroprevalence of HCV is about 20% among haemodialysed patients. This study aimed at describing the French screening practices in haemodialysed patients. In 1995, 1213 self-administered questionnaires were sent to nephrologists working in 715 dialysis units. The response rate was 48% (585/1213) and 485 questionnaires were analysed. In 98% of questionnaires nephrologists answered that they prescribed screening test. Routine screening with alanine amino-transferase (ALT) was reported in 98% of questionnaires, usually once a month (57%) or four times a year (23%). Routine anti-HCV serology was reported by 96%, usually once (28%) or twice (46%) a year. The two main annual strategies combining ALT and anti-HCV serology were 12 ALT and 2 serologies (21%), or 12 ALT and 1 serology (14%) per year. HCV RNA detection was reported mainly in the case of positive anti-HCV serology (70%). The study suggested heterogeneity in screening practices and revealed the need to determine the cost-effectiveness ratios of the various strategies.
|
| pubmed:language |
fre
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0250-4960
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
19
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
217-22
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:9675762-Adult,
pubmed-meshheading:9675762-Alanine Transaminase,
pubmed-meshheading:9675762-Biological Markers,
pubmed-meshheading:9675762-Biopsy, Needle,
pubmed-meshheading:9675762-Blood Transfusion,
pubmed-meshheading:9675762-Comorbidity,
pubmed-meshheading:9675762-Cost-Benefit Analysis,
pubmed-meshheading:9675762-Female,
pubmed-meshheading:9675762-France,
pubmed-meshheading:9675762-Hepatitis C,
pubmed-meshheading:9675762-Hepatitis C Antibodies,
pubmed-meshheading:9675762-Humans,
pubmed-meshheading:9675762-Immunologic Techniques,
pubmed-meshheading:9675762-Interferons,
pubmed-meshheading:9675762-Kidney Failure, Chronic,
pubmed-meshheading:9675762-Kidney Transplantation,
pubmed-meshheading:9675762-Liver,
pubmed-meshheading:9675762-Male,
pubmed-meshheading:9675762-Mass Screening,
pubmed-meshheading:9675762-Middle Aged,
pubmed-meshheading:9675762-Nephrology,
pubmed-meshheading:9675762-Physician's Practice Patterns,
pubmed-meshheading:9675762-Prevalence,
pubmed-meshheading:9675762-Questionnaires,
pubmed-meshheading:9675762-Renal Dialysis,
pubmed-meshheading:9675762-Seroepidemiologic Studies,
pubmed-meshheading:9675762-Serologic Tests,
pubmed-meshheading:9675762-Travel
|
| pubmed:year |
1998
|
| pubmed:articleTitle |
[National study of screening practices for hepatitis C among hemodialysis patients. Hepatitis Group].
|
| pubmed:affiliation |
Département d'information médicale des Hospices civils de Lyon.
|
| pubmed:publicationType |
Journal Article,
English Abstract
|